23. Prion disease Disease details / Clinical trials / Drug dev / DR info /
Clinical trials : 5 / Drugs : 6 - (DrugBank : 2) / Drug target gene : 0 - Drug target pathway : 0
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Bassado
IST. DI RICERCHE FARMACOLOG. M. NEGRI
2011 Phase 3 EUCTR2010-022233-28-IT Italy
Bassado 10CPS 100MG
ISTITUTO NEUROLOGICO CARLO BESTA
2006 - EUCTR2006-001858-27-IT Italy
Doxycycline
ISTITUTO NEUROLOGICO CARLO BESTA
2006 - EUCTR2006-001858-27-IT Italy
Doxycycline hyclate
IST. DI RICERCHE FARMACOLOG. M. NEGRI
2011 Phase 3 EUCTR2010-022233-28-IT Italy
ION717
Ionis Pharmaceuticals, Inc.
2024 Phase 1/Phase 2 NCT06153966 Australia;Canada;France;Germany;Israel;Italy;Japan;Spain;United States
Quinacrine
Medical Research Council
2004 - NCT00104663 United Kingdom
University of California, San Francisco
2005 Phase 2 NCT00183092 United States
IST. DI RICERCHE FARMACOLOG. M. NEGRI
2011 Phase 3 EUCTR2010-022233-28-IT Italy
Bassado 10CPS 100MG
ISTITUTO NEUROLOGICO CARLO BESTA
2006 - EUCTR2006-001858-27-IT Italy
Doxycycline
ISTITUTO NEUROLOGICO CARLO BESTA
2006 - EUCTR2006-001858-27-IT Italy
Doxycycline hyclate
IST. DI RICERCHE FARMACOLOG. M. NEGRI
2011 Phase 3 EUCTR2010-022233-28-IT Italy
ION717
Ionis Pharmaceuticals, Inc.
2024 Phase 1/Phase 2 NCT06153966 Australia;Canada;France;Germany;Israel;Italy;Japan;Spain;United States
Quinacrine
Medical Research Council
2004 - NCT00104663 United Kingdom
University of California, San Francisco
2005 Phase 2 NCT00183092 United States